Cite
Fukuda T, Kawanishi M, Awazu Y, et al. Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma. Mol Clin Oncol. 2021;15(4):217doi: 10.3892/mco.2021.2381.
Fukuda, T., Kawanishi, M., Awazu, Y., Nanno, S., Shimomura, M., Inoue, Y., Matsubara, H., Yamauchi, M., Kasai, M., Hashiguchi, Y., Ichimura, T., Yasui, T., & Sumi, T. (2021). Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma. Molecular and clinical oncology, 15(4), 217. https://doi.org/10.3892/mco.2021.2381
Fukuda, Takeshi, et al. "Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma." Molecular and clinical oncology vol. 15,4 (2021): 217. doi: https://doi.org/10.3892/mco.2021.2381
Fukuda T, Kawanishi M, Awazu Y, Nanno S, Shimomura M, Inoue Y, Matsubara H, Yamauchi M, Kasai M, Hashiguchi Y, Ichimura T, Yasui T, Sumi T. Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma. Mol Clin Oncol. 2021 Oct;15(4):217. doi: 10.3892/mco.2021.2381. Epub 2021 Aug 25. PMID: 34476101; PMCID: PMC8408678.
Copy
Download .nbib